OpenAI acquires Orchestra Bio to bolster its biotech division
In brief
- OpenAI acquires Orchestra Bio to strengthen its biotech division.
- The team and technology will be integrated into Rosalind, its life sciences AI model.
- Rosalind Workbench assists researchers in planning and analyzing experiments.
OpenAI has acquired startup Orchestra Bio, whose team and technology will be integrated into Rosalind, its AI model for life sciences research, and its Rosalind Workbench tool that helps researchers design and analyze experiments, according to the company.
What it changes for you
- HealthOpenAI's tools could speed up medical research in life sciences through enhanced integration.
This summary gives you the essentials. The full article, its figures and quotes are on AI News & Artificial Intelligence | TechCrunch.
Read the original articleAI-generated summary of the source, checked by rules. How we write · Report an error